TY - JOUR
T1 - Accuracy of rapid antigen detection test for nasopharyngeal swab specimens and saliva samples in comparison with RT-PCR and viral culture for SARS-CoV-2 detection
AU - Keio Donner Project Members
AU - Uwamino, Yoshifumi
AU - Nagata, Mika
AU - Aoki, Wataru
AU - Nakagawa, Terumichi
AU - Inose, Rika
AU - Yokota, Hiromitsu
AU - Furusawa, Yuri
AU - Sakai-Tagawa, Yuko
AU - Iwatsuki-Horimoto, Kiyoko
AU - Kawaoka, Yoshihiro
AU - Hasegawa, Naoki
AU - Murata, Mitsuru
N1 - Funding Information:
This study was funded by Research Funds of Keio University School of Medicine and partly supported by a Research Program on Emerging and Re-emerging Infectious Diseases (grant no. JP19fk0108113 ), the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) (JP19fm0108006), and Japan Program for Infectious diseases Research and Infrastructure (JP20wm0125002) of the Japan Agency for Medical Research and Development (AMED) and by the National Institutes of Allergy and Infectious Diseases-funded Center for Research on Influenza Pathogenesis (grant no. HHSN272201400008C ).
Publisher Copyright:
© 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases
PY - 2021/7
Y1 - 2021/7
N2 - Introduction: Rapid antigen detection (RAD) tests are convenient tools for detecting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in clinics, and testing using saliva samples could decrease the risk of infection during sample collection. This study aimed to assess the accuracy of the SARS-CoV-2 RAD for testing of nasopharyngeal swab specimens and saliva samples in comparison with the RT-PCR tests and viral culture for detecting viable virus. Methods: One hundred seventeen nasopharyngeal swab specimens and 73 saliva samples with positive results on RT-PCR were used. Residual samples were assayed using a commercially available RAD test immediately, and its positivity was determined at various time points during the clinical course. The concordance between 54 nasopharyngeal swab samples and saliva samples that were collected simultaneously was determined. Viral culture was performed on 117 samples and compared with the results of the RAD test. Results: The positive rate of RAD test using saliva samples was low throughout the clinical course. Poor concordance was observed between nasopharyngeal swab specimens and saliva samples (75.9%, kappa coefficient 0.310). However, a substantially high concordance between the RAD test and viral culture was observed in both nasopharyngeal swab specimens (86.8%, kappa coefficient 0.680) and saliva samples (95.1%, kappa coefficient 0.643). Conclusions: The sensitivity of the SARS-CoV-2 RAD test was insufficient, particularly for saliva samples. However, a substantially high concordance with viral culture suggests its potential utility as an auxiliary test for estimating SARS-CoV-2 viability.
AB - Introduction: Rapid antigen detection (RAD) tests are convenient tools for detecting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in clinics, and testing using saliva samples could decrease the risk of infection during sample collection. This study aimed to assess the accuracy of the SARS-CoV-2 RAD for testing of nasopharyngeal swab specimens and saliva samples in comparison with the RT-PCR tests and viral culture for detecting viable virus. Methods: One hundred seventeen nasopharyngeal swab specimens and 73 saliva samples with positive results on RT-PCR were used. Residual samples were assayed using a commercially available RAD test immediately, and its positivity was determined at various time points during the clinical course. The concordance between 54 nasopharyngeal swab samples and saliva samples that were collected simultaneously was determined. Viral culture was performed on 117 samples and compared with the results of the RAD test. Results: The positive rate of RAD test using saliva samples was low throughout the clinical course. Poor concordance was observed between nasopharyngeal swab specimens and saliva samples (75.9%, kappa coefficient 0.310). However, a substantially high concordance between the RAD test and viral culture was observed in both nasopharyngeal swab specimens (86.8%, kappa coefficient 0.680) and saliva samples (95.1%, kappa coefficient 0.643). Conclusions: The sensitivity of the SARS-CoV-2 RAD test was insufficient, particularly for saliva samples. However, a substantially high concordance with viral culture suggests its potential utility as an auxiliary test for estimating SARS-CoV-2 viability.
KW - Nasopharyngeal swabs
KW - Rapid antigen detection test
KW - SARS-CoV-2
KW - Saliva
KW - Viral culture
UR - http://www.scopus.com/inward/record.url?scp=85104964897&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104964897&partnerID=8YFLogxK
U2 - 10.1016/j.jiac.2021.04.010
DO - 10.1016/j.jiac.2021.04.010
M3 - Article
C2 - 33934920
AN - SCOPUS:85104964897
SN - 1341-321X
VL - 27
SP - 1058
EP - 1062
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
IS - 7
ER -